Antihypertensive effect of insulin via nitric oxide production in the Zucker diabetic fatty rat, an animal model for non-insulin-dependent diabetes mellitus

European Journal of Endocrinology

Volumn 140, Issue 4, 1999, Pages 341-349

  Kawaguchi, Mikiko ^a   Koshimura, Kunio ^a   Murakami, Yoshio ^a   Tsumori, Michihiro ^a   Gonda, Tatsuo ^a   Kato, Yuzuru ^a  

^a SHIMANE UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; ISOPHANE INSULIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; BLOOD PRESSURE REGULATION; BODY WEIGHT; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVATION; ENZYME ACTIVITY; FOOD INTAKE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GUINEA PIG; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0032940185     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1400341     Document Type: Article

References (49)

1. Mehler PS, Jeffers BW, Estacio R & Schrier RW. Association of hypertension and complications in non-insulin-dependent diabetes mellitus. American Journal of Hypertension 1997 10 152-161.
2. Meigs JB, Singer DE, Sullivan LM, Dukes KA, D'Agostino RB, Nathan DM et al. Metabolic control and prevalent cardiovascular disease in non-insulin-dependent diabetes mellitus (NIDDM): the NIDDM patient outcome research team. American Journal of Medicine 1997 102 38-47.
3. Hall JE, Coleman TG, Mizelle HL & Smith MJ Jr. Chronic hyperinsulinemia and blood pressure regulation. American Journal of Physiology 1990 258 F722-F731.
4. Hall JE, Brands MW, Kivlighn SD, Mizelle HL, Hildebrandt DA & Gaillard CA. Chronic hyperinsulinemia and blood pressure: interaction with catecholamine? Hypertension 1990 15 519-527.
5. Brands MW, Mizelle HL, Gaillard CA, Hildebrandt DA & Hall JE. The hemodynamic response to chronic hyperinsulinemia in conscious dogs. American Journal of Hypertension 1991 4 164-168.
6. Baron AD & Brechtel G. Insulin differentially regulates systemic and skeletal muscle vascular resistance. American Journal of Physiology 1993 265 E61-E67.
7. Baron AD, Brechtel-Hook G, Johnson A & Hardin D. Skeletal muscle blood flow: a possible link between insulin resistance and blood pressure. Hypertension 1993 21 129-135.
8. Gans RO, Bilo HJ & Donker AJ. The renal response to exogenous insulin in non-insulin-dependent diabetes mellitus in relation to blood pressure and cardiovascular hormonal status. Nephrology, Dialysis, Trasnsplantation 1996 11 794-802.
9. Giugliano D, Marfella R, Verrazzo G, Acampora R, Coppola L, Cozzolino D et al. The vascular effects of L-arginine in humans -the role of endogenous insulin. Journal of Clinical Investigation 1997 99 433-438.
10. Anderson EA, Hoffman RP, Balon TW, Sinkey CA & Mark AL. Hyperinsulinemia produces both sympathetic neural activation and vasodilatation in normal humans. Journal of Clinical Investigation 1991 87 2246-2252.
11. Anderson EA & Mark AL. The vasodilator action of insulin: implications for the insulin hypothesis of hypertension. Hypertension 1993 21 136-141.
12. Baron AD. Hemodynamic actions of insulin. American Journal of Physiology 1994 267 E187-E202.
13. Scott AR, Bennet T & Macdonald IA. Effects of hyperinsulinemia on the cardiovascular responses to graded hypovolemia in normal and diabetic subjects. Clinical Science 1988 75 85-92.
14. Natali A, Buzzigoli G, Taddei S, Santori D, Cerri M, Pedrinelli R et al Effects of insulin on hemodynamics and metabolism in human forearm. Diabetes 1990 39 490-500.
15. Anderson EA, Hoffmann RP, Balon TW, Sinkey CA & Mark AL. Hyperinsulinemia in humans increases muscle sympathetic nerve activity, but reduces forearm vascular resistance. Clinical Research 1990 20 219-225.
16. Vollenweider P, Tappy L, Randin D, Schneiter P, Jequier E, Nicod P et al. Differential effects of hyperinsulinemia and carbohydrate metabolism on sympathetic nerve activity and muscle blood flow in humans. Journal of Clinical Investigation 1993 92 147-154.
17. Folkow B. Hypertensive structural changes in systemic precapillary resistance vessels: how important are they for in vivo hemodynamics? Journal of Hypertension 1995 13 1546-1559.
18. Heagerty AM & Izzard AS. Small-artery changes in hypertension. Journal of Hypertension 1995 13 1560-1565.
19. Heistad DD, Baumbach GL, Faraci FM & Armstrong ML. Sick vessels syndrome: vascular changes in hypertension and athero-sclerosis. Journal of Human Hypertension 1995 9 449-453.
20. Izzard AS & Heagerty AM. Hypertension and the vasculature: arterioles and the myogenic response. Journal of Hypertension 1995 13 1-4.
21. Vane JR, Änggård EE & Botting RM. Mechanisms of disease: regulatory functions of the vascular endothelium. New England Journal of Medicine 1990 323 27-36.
22. Dinerman JL, Lowenstein CJ & Snyder SH. Molecular mechanisms of nitric oxide regulation: potential relevance to cardiovascular diseases. Circulation Research 1993 73 217-222.
23. Sobrevia L, Nadal A, Yudilevich DL & Mann GE. Activation of L-arginine transport (system y+) and nitric oxide synthase by elevated glucose and insulin in human endothelial cells. Journal of Physiology 1996 490 775-781.
24. Zeng G & Quon MJ. Insulin-stimulated production of nitric oxide is inhibited by wortmannin: direct measurement in vascular endothelial cells. Journal of Clinical Investigation 1996 98 894-898.
25. 3- excretion. Metabolism 1997 46 406-409.
26. Scherrer U, Randin D, Vollenweider P, Vollenweider L & Nicod O. Nitric oxide release accounts for insulin's vascular effects in humans. Journal of Clinical Investigation 1994 94 2511-2515.
27. Steinberg HO, Brechtel G, Johnson A, Fineberg N & Baron AD. Insulin-mediated skeletal muscle vasodilatation is nitric oxide dependent: a novel action of insulin to increase nitric oxide release. Journal of Clinical Investigation 1994 94 1172-1179.
28. McKay MK & Hester RL. Role of nitric oxide, adenosine, and ATP-sensitive potassium channels in insulin-induced vasodilatation. Hypertension 1996 28 202-208.
29. Avogaro A, Piarulli F, Varelio A. Miola M, Calveri M, Pavan P et al. Forearm nitric oxide balance, vascular relaxation, and glucose metabolism in NIDDM patients. Diabetes 1997 46 1040-1046.
30. Clark JB, Palmer CJ & Shaw WN. The diabetic zucker fatty rat. Proceedings of the Society for Experimental Biology and Medicine 1983 17 368-75.
31. Tanigawa K, Kawaguchi M, Tanaka O & Kato Y. Skeletal malformations in rat offspring: long-term effect of maternal insulin-induced hypoglycemia during organogenesis. Diabetes 1991 40 1115-1121.
32. Kawaguchi M, Tanigawa K & Kato Y. A study of the effect of CS-045. a new antidiabetic drug, on hypertension in spontaneously hypertensive rat. Endocrine Journal 1995 42 557-561.
33. Deabuquois B & Aurbach GD. Use of polyethylene glycol to separate free and antibody-bound peptide hormones in radioimmunoassays. Journal of Clinical Endocrinology and Metabolism 1971 33 732-738.
34. Kawaguchi M, Tanigawa K, Tanaka O & Kato Y. Embryonic growth impaired by maternal hypoglycemia during early organogenesis in normal and diabetic rats. Acta Diabetologica 1994 31 141-146.
35. Xu G, Tanigawa K, Nakamura S, Kawaguchi M, Kato Y & Tamura K. β-Cell function and replication in spontaneously hypertensive rats. Metabolism 1995 44 1360-1364.
36. Inoue Y, Tanigawa K, Nakamura S, Xu G, Kawaguchi M, Kato Y et al. Lack of effect of CS-045, a new antidiabetic agent, on insulin secretion in the remnant pancreas after 90% pancreatectomy in rats. Diabetes Research and Clinical Practice 1995 27 19-26.
37. Tanigawa K, Xu G, Nakamura S, Kawaguchi M, Kato Y & Tamura K. Impaired compensatory adaptation to B-cell mass reduction in young spontaneously hypertensive rats (SHR). Pancreas 1996 12 237-242.
38. Reaven GM, Lithell H & Landsberg L. Hypertension and associated metabolic abnormalities - the role of insulin resistance and the sympathoadrenal system. New England Journal of Medicine 1996 334 374-381.
39. Baron AD. The coupling of glucose metabolism and perfusion in human skeletal muscle: the potential role of endothelium-derived nitric oxide. Diabetes 1996 45 (Suppl) S105-S109.
40. Laakso M, Edelman SV, Brechtel G & Baron AD. Decreased effect of insulin to stimulate skeletal muscle blood flow in obese man: a novel mechanism for insulin resistance. Journal of Clinical Investigation 1990 85 1844-1852.
41. Laakso M, Edelman SU, Brechtel G & Baron AD. Impaired insulin-mediated skeletal muscle blood flow in patients with NIDDM. Diabetes 1992 41 1076-1083.
42. Steinberg HO, Chaker H, Learning R, Johnson A, Brechtel G & Baron AD. Obesity/insulin resistance is associated with endothelial dysfunction - implications for the syndrome of insulin resistance. Journal of Clinical Investigation 1996 97 2601-2610.
43. Gans RO, v.d. Toorn L, Bilo HJG, Nauta JJP, Heine RJ & Donker AJM. Renal and cardiovascular effects of exogenous insulin in healthy volunteers. Clinical Science 1991 80 219-225.
44. Panagiotidis G, Alm P & Lundquist I. Inhibition of islet nitric oxide synthase increases arginine-induced insulin release. European Journal of Pharmacology 1992 229 277-278.
45. Coiro V, Volpi R, Capretti L, Speroni G, Caffarri G & Chiodera P Involvement of nitric oxide in arginine, but not glucose, induced insulin secretion in normal men. Clinical Endocrinology 1997 46 115-119.
46. Boden G, Ruiz J, Urbain JL & Chen X. Evidence for a circadian rhythm of insulin secretion. American Journal of Physiology 1996 271 E246-E252.
47. Busse R, Fleming I & Hecker M. Signal transduction in endothelium-dependent vasodilatation. European Heart Journal 1993 14 (Suppl 1) 2-9.
48. Vanhoutte PM & Mombouli JV, Vascular endothelium: vasoactive mediators. Progress in Cardiovascular Diseases 1996 39 229-238.
49. Vanhoutte PM. Endothelium and control of vascular function: state of art lecture. Hypertension 1989 13 658-667.